/td> [8] Chow, C.K., Jolly, S., Rao-Melacini, P., Fox, K.A., Anand, S.S. and Yusuf, S. (2010) Association of Diet, Exercise, and Smoking Modification with Risk of Early Cardiovascular Events after Acute Coronary Syndromes. Circulation, 121, 750-758.
http://dx.doi.org/10.1161/CIRCULATIONAHA.109.891523 [9] Scholte op Reimer, W., de Swart, E., et al. (2006) Smoking Behavior in European Patients with Established Coronary Heart Disease. European Heart Journal, 27, 35-41.
http://dx.doi.org/10.1093/eurheartj/ehi497 [10] Reid, R.D., Mullen, K.A., Slovinec D’Angelo, M.E., et al. (2010) Smoking $cessation for Hospitalized Smokers: An Evaluation of the “Ottawa Model”. Nicotine & Tobacco Research, 12, 11-18.
http://dx.doi.org/10.1093/ntr/ntp165 [11] Boggon, R., Timmis, A., Hemingway, H., Raju, S., Malvestiti, F.M. and Van Staa, T.P. (2014) Smoking Cessation Interventions Following Acute Coronary Syndrome: A Missed Opportunity? European Journal of Preventive Cardiology, 21, 767-773.
http://dx.doi.org/10.1177/2047487312460517 [12] Abu-Baker, N.N., Haddad, L. and Mayyas, O. (2010) Smoking Behavior among Coronary Heart Disease Patients in Jordan: A Model from a Developing Country. International Journal of Environmental Research and Public Health, 7, 751-764.
http://dx.doi.org/10.3390/ijerph7030751 [13] Hammoudeh, A.J. (2002) Cigarette Smoking Cessation among Jordanians after Sustaining Acute Coronary Events: The Impact of Undergoing Coro-nary Revascularization. Jordan Medical Journal, 36, 122-125. [14] Alhaddad, I., Hammoudeh, A., Al Mousa, E., Jarrah, M., Saleh, A., Qaqa, Z., Janabi, J., Kharabsheh, H., Hazaimeh, L. and Khader, Y. (2015) Middle Eastern Patients Undergoing Percutaneous Coronary Intervention: Factors That Impact In-Hospital and One Year Outcome. Results from the First Jordanian PCI Registry (JoPCR 1). European Heart Journal, 36, 764. [15] Amsterdam, E.A., Wenger, N.K., Brindis, R.G., Casey, D.E., Ganiats, T.G., Holmes Jr., D.R., Jaffe, A.S., Jneid, H., Kelly, R.F., Kontos, M.C., Levine, G.N., Liebson, P.R., Mukherjee, D., Peterson, E.D., Sabatine, M.S., Smalling, R.W. and Zieman, S.J. (2014) AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, 130, e344-e426.
http://dx.doi.org/10.1161/CIR.0000000000000134 [16] Cutlip, D.E., Windecker, S., Mehran, R., Boam, A., Cohen, D.J., van Es, G.E., Steg, P.G., Morel, M.A., Mauri, L., Vranckx, P., Mc Fadden, E., Lansky, A., Hamon, M., Krucoff, M.W. and Serruys, P.W. (2007) On Behalf of the Academic Research Consortium. Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions. Circulation, 115, 2344-2351.
http://dx.doi.org/10.1161/CIRCULATIONAHA.106.685313 [17] Subherwal, S., Bach, R.G., Chen, A.Y., Gage, B.F., Rao, S.V., Newby, L.K., Wang, T.Y., Gibler, W.B., Ohman, E.M., Roe, M.T., Pollack Jr, C.V., Peterson, E.D. and Alexander, K.P. (2009) Baseline Risk of Major Bleeding in Non-ST-Segment Elevation Myocardial Infarction: The CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients SUPPRESS Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines) Bleeding Score. Circulation, 119, 1873-1882.
http://dx.doi.org/10.1161/CIRCULATIONAHA.108.828541 [18] Van Spall, H.G.C., Chong, A. and Tu, J.V. (2007) Inpatient Smoking-Cessation Counseling and All-Cause Mortality in Patients with Acute Myocardial Infarction. American Heart Journal, 152, 213-220.
http://dx.doi.org/10.1016/j.ahj.2007.04.012 [19] Kinjo, K., Sato, H., Sakata, Y., et al. (2005) Impact of Smoking Status on Long-Term Mortality in Patients with Acute Myocardial Infarction. Circulation Journal, 69, 7-12.
http://dx.doi.org/10.1253/circj.69.7 [20] Critchley, J.A. and Capewell, S. (2003) Mortality Risk Reduction Associated with Smoking Cessation in Patients with Coronary Heart Disease: A Systematic Review. JAMA, 290, 86-97.
http://dx.doi.org/10.1001/jama.290.1.86 [21] Larsen, G.K., Seth, M. and Gurm, H.S. (2013) The Ongoing Importance of Smoking as a Powerful Risk Factor for ST-Segment Elevation Myocardial Infarction in Young Patients. JAMA Internal Medicine, 173, 1261-1262.
http://dx.doi.org/10.1001/jamainternmed.2013.6075 [22] Hasdai, D., Garratt, K.N., Grill, D.E., Lerman, A. and Holmes Jr., D.R. (1997) Effect of Smoking Status on the Long-Term Outcome after Successful Percutaneous Coronary Revascularization. The New England Journal of Medicine, 336, 755-761.
http://dx.doi.org/10.1056/NEJM199703133361103 [23] Rallidis, L.S., Hamodraka, E.S., Foulidis, V.O. and Pavlakis, G.P. (2005) Persistent Smokers after Myocardial Infarction: A Group That Re-quires Special Attention. International Journal of Cardiology, 100, 241-245.
http://dx.doi.org/10.1016/j.ijcard.2004.08.040 [24] Eisenberg, M.J., Grandi, S.M. and Gervais, A. (2013) Bupropion for Smoking Cessation in Patients Hospitalized with Acute Myocardial Infarction: A Randomized, Placebo-Controlled Trial. Journal of the American College of Cardiology, 61, 524-532.
http://dx.doi.org/10.1016/j.jacc.2012.08.1030 [25] Rigotti, N.A., Pipe, A.L., Benowitz, N.L., Arteaga, C., Garza, D. and Tonstad, S. (2010) Efficacy and Safety of Varenicline for Smoking Cessation in Patients with Cardiovascular Disease: A Randomized Trial. Circulation, 121, 221-229.
http://dx.doi.org/10.1161/CIRCULATIONAHA.109.869008 [26] Perk, J., Hambraeus, K., Burell, G., Carlsson, R., Johansson, P. and Lisspers, J. (2015) Study of Patient Information after Percutaneous Coronary Intervention (SPICI): Should Prevention Programmes Become More Effective? EuroIntervention, 10, e1-e7.
http://dx.doi.org/10.4244/EIJV10I11A223 [27] Sochor, O., Lennon, R.J., Bresnahan, J., Croghan, I., Pack, Q., Rodriguez Escudero, J.P., Kara, T., Somers, V., Lopez-Jimenez, F. and Thomas, R. (2012) Trends and Predictors of Smoking Cessation after Percutaneous Coronary Intervention: Experience from Olmsted County, Minnesota, 1999-2010. Journal of the American College of Cardiology, 59, E1882-E1882.
http://dx.doi.org/10.1016/S0735-1097(12)61883-X [28] Dawood, N., Vaccarino, V., Reid, K.J., Spertus, J.A., Hamid, N. and Parashar, S. (2008) Predictors of Smoking Cessation after a Myocardial Infarction: The Role of Institutional Smoking Cessation Programs in Improving Success. Archives of Internal Medicine, 168, 1961-1967.
http://dx.doi.org/10.1001/archinte.168.18.1961 [29] Kim, H.E., Song, Y.M., Kim, B.K. and Kim, M.H. (2013) Factors Associated with Persistent Smoking after the Diagnosis of Cardiovascular Disease. Korean Journal of Family Medicine, 34, 160-168.
http://dx.doi.org/10.4082/kjfm.2013.34.3.160 [30] Hymowitz, N., Cummings, K.M., Hyland, A., Lynn, W.R., Pechacek, T.F. and Hartwell, T.D. (1997) Predictors of Smoking Cessation in a Cohort of Adult Smokers Followed for Five Years. Tobacco Control, 6, S57-S62.
http://dx.doi.org/10.1136/tc.6.suppl_2.S57 [31] Gerber, Y., Goldbourt, U. and Drory, Y. (2008) Interaction between Income and Education in Predicting Long-Term Survival after Acute Myocardial Infarction. European Journal of Cardiovascular Prevention & Rehabilitation, 15, 526-532.
http://dx.doi.org/10.1097/HJR.0b013e328304feac [32] Pipe, A., Eisenberg, M.J., Gupta, A., et al. (2011) Society Position Statement: Smoking Cessation and the Cardiovascular Specialist: Canadian Cardiovascular Society Position Paper. Canadian Journal of Cardiology, 27, 132-137.
http://dx.doi.org/10.1016/j.cjca.2010.12.060 [33] Grainger Gasser, A., Welch, C., Arora, M., Reid, R.D., Suskin, N.G. and Stone, J.A. (2015) Reducing Cardiovascular Mortality through Tobacco Control. A World Heart Federation Roadmap. Global Heart, 10, 123-133.
http://dx.doi.org/10.1016/j.gheart.2015.04.007 [34] Granger, C.B., Goldberg, R.J., Dabbous, O., Pieper, K.S., Eagle, K.A., Cannon, C.P., Van Der Welf, E., Avezum, A., Goodman, S.G., Flather, M.D. and Fox, K.A. (2013) Global Registry of Acute Coronary Events Investigators. Predictors of Hospital Mortality in the Global Registry of Acute Coronary Events. Archives of Internal Medicine, 163, 2345-2353.
http://dx.doi.org/10.1001/archinte.163.19.2345 [35] Mikhail, G.W., Gerber, R.T., Cox, D.A., Ellis, S.G., Lasala, G.M., Orminston, J.A., Stone, G.W., Turco, M.A., Joshi, A.A., Baim, D.S. and Colombo, A. (2010) Influence of Sex on Long-Term Outcomes after Percutaneous Coronary Intervention with the Paclitaxel-Eluting Coronary Stent. JACC: Cardiovascular Interventions, 3, 1250-1259.
http://dx.doi.org/10.1016/j.jcin.2010.08.020 [36] James, S., Angiolillo, D.J., Cornel, J.H., Erlinge, D., Husted, S., Kontny, F., Maya, J., Nicolau, J.C., Spinar, J., Storey, R.F., Stevens, S.R. and Wallentin, L. (2010) PLATO Study Group. Ticagrelor vs. Clopidogrel in Patients with Acute Coronary Syndromes and Diabetes: A Substudy from the Platelet Inhibition and Patient Outcomes (PLATO) Trial. European Heart Journal, 31, 3006-3016.
http://dx.doi.org/10.1093/eurheartj/ehq325 [37] Wilson, W.M., Andrianopoulos, N., Clark, D., Duffy, S.J., Brennan, A., Harries, I., New, G., Sebastian, M., Loane, P., Reid, C. and Ajani, A.E. (2011) Long-Term Predictors of Mortality after Percutaneous Coronary Intervention in the Era of Drug-Eluting Stents. American Journal of Cardiology, 108, 936-942.

comments powered by Disqus
WJCD Subscription
E-Mail Alert
WJCD Most popular papers
Publication Ethics & OA Statement
Frequently Asked Questions
Recommend to Peers
Recommend to Library
Contact Us

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.